"Dick" Stiehm and I have been colleagues and friends for a long time, dating back to the golden days at Philadelphia (Pa) General Hospital, when we were both interns. We have authored a text together and dealt with similar issues in our research careers. Dick has been a valuable contributor to AJDC, offering his insightful critiques on articles, suggesting ways that the journal could be improved, soliciting state-of-the-art articles for us, and offering nonmedical observations that stimulate our readers to respond. His contribution at right continues this last-named tradition.
Dick is one of the most respected pediatric immunologists in the world. He is regarded as an expert in many areas, and his work has influenced the use of immunoglobulin therapy, particularly the newer intravenous preparations. He has contributed to our understanding of congenital and acquired immunodeficiencies, to our knowledge and use of vaccines, and to the unraveling of basic immunologic